Gene Therapy for Sickle Cell Disease, β-Thalassemia Enters Regulatory Reviews

被引：0
作者：
Larkin, Howard D.
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2022年 / 328卷 / 18期
关键词：
D O I：
10.1001/jama.2022.18448
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1798 / 1798
页数：1
相关论文
共 50 条
[31]   Gene Therapy in a Patient with Sickle Cell Disease [J].
Badat, Mohsin ;
Davies, James .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (21) :2093-2094
[32]   ERYTHROPOIETIN THERAPY IN INHERITED ANEMIAS (THALASSEMIA AND SICKLE-CELL DISEASE) [J].
OLIVIERI, NF .
INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY, 1995, 2 (02) :105-116
[33]   SICKLE-CELL DISEASE AND THALASSEMIA [J].
FULLER, J .
PRACTITIONER, 1993, 237 (1525) :344-&
[34]   SICKLE-CELL DISEASE AND THALASSEMIA [J].
KLEILER, K .
AMERICAN JOURNAL OF MEDICAL TECHNOLOGY, 1978, 44 (11) :1108-1113
[35]   Mitapivat for sickle cell disease and thalassemia [J].
Pilo, Federica ;
Angelucci, Emanuele .
DRUGS OF TODAY, 2023, 59 (03) :125-134
[36]   Gene Therapy Should Be the Cell Therapy of Choice for Sickle Cell Disease [J].
Boelens, Jaap Jan .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 :S133-S134
[37]   FIRST OBSERVATION OF HOMOZYGOUS HEMOGLOBIN S-ALPHA THALASSEMIA DISEASE AND 2 TYPES OF SICKLE CELL THALASSEMIA DISEASE - (A) SICKLE CELL-ALPHA THALASSEMIA DISEASE, (B) SICKLE CELL-BETA THALASSEMIA DISEASE [J].
AKSOY, M .
BLOOD, 1963, 22 (06) :757-&
[38]   USING HUDEP CELLS AS A MODEL FOR GENE EDITING FOR -THALASSEMIA AND SICKLE CELL DISEASE [J].
Velez, Miriam ;
Sanchez, Julie ;
Miggelbrink, Alexandra ;
Romero, Zulema ;
Kohn, Donald .
EXPERIMENTAL HEMATOLOGY, 2018, 64 :S108-S108
[39]   CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia [J].
Haydar Frangoul .
四川生理科学杂志, 2020, 42 (04) :506-506
[40]   CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia [J].
Lakshmi, Dhanya N. .
INDIAN PEDIATRICS, 2022, 59 (06) :458-458
12345